![conference banner](/images/conference-banner.jpeg)
Abstract
Asthma is a chronic disease of the airways affecting around 10% of the population. The majority of cases are well controlled with current therapies, however in approximately 20% of severe asthmatics the available therapeutic strategies are inadequate. Structural changes in the asthmatic airway, including an increase in smooth muscle mass and an increased deposition of extracellular matrix proteins, which correlate with airway hyperresponsivenes, reduced lung function and an increase in fibroblast/myofibroblast numbers, are not specifically targetted by current therapeutic agents and therefore represent an area of unmet need. The mechanisms involved in the development of airway remodelling are incompletely understood but are thought to involve one or more isoforms of transforming growth factor-β (TGF-β). The TGF-βs are pleiotropic mediators which have important roles in the regulation of inflammation, cell growth, differentiation and wound healing. All three mammalian isoforms of TGF-b are present in the airways and at least TGF-β1 and TGF- β2 have been shown to be increased in asthmatic airways and cells, together with evidence of increased TGF-β signalling. In addition, evidence from animal models suggests that airway remodelling may be prevented or reversed using agents which target TGF-β. Therefore modulation of TGF-βs or their activity represent a potential therapeutic target for asthma. This review focuses on the current knowledge of TGF-β1-3, their their role in normal and asthmatic airways, as well as the potential for modulating the TGF-βs and their effects as a therapeutic approach to asthma.
Keywords: TGF-β, asthma, drug target, remodelling, airways
Current Drug Targets
Title: TGF-β: Its Role in Asthma and Therapeutic Potential
Volume: 7 Issue: 5
Author(s): Jane E. Howell and Robin J. McAnulty
Affiliation:
Keywords: TGF-β, asthma, drug target, remodelling, airways
Abstract: Asthma is a chronic disease of the airways affecting around 10% of the population. The majority of cases are well controlled with current therapies, however in approximately 20% of severe asthmatics the available therapeutic strategies are inadequate. Structural changes in the asthmatic airway, including an increase in smooth muscle mass and an increased deposition of extracellular matrix proteins, which correlate with airway hyperresponsivenes, reduced lung function and an increase in fibroblast/myofibroblast numbers, are not specifically targetted by current therapeutic agents and therefore represent an area of unmet need. The mechanisms involved in the development of airway remodelling are incompletely understood but are thought to involve one or more isoforms of transforming growth factor-β (TGF-β). The TGF-βs are pleiotropic mediators which have important roles in the regulation of inflammation, cell growth, differentiation and wound healing. All three mammalian isoforms of TGF-b are present in the airways and at least TGF-β1 and TGF- β2 have been shown to be increased in asthmatic airways and cells, together with evidence of increased TGF-β signalling. In addition, evidence from animal models suggests that airway remodelling may be prevented or reversed using agents which target TGF-β. Therefore modulation of TGF-βs or their activity represent a potential therapeutic target for asthma. This review focuses on the current knowledge of TGF-β1-3, their their role in normal and asthmatic airways, as well as the potential for modulating the TGF-βs and their effects as a therapeutic approach to asthma.
Export Options
About this article
Cite this article as:
Howell E. Jane and McAnulty J. Robin, TGF-β: Its Role in Asthma and Therapeutic Potential, Current Drug Targets 2006; 7 (5) . https://dx.doi.org/10.2174/138945006776818692
DOI https://dx.doi.org/10.2174/138945006776818692 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response, and/or therapy ...read more
![Wayfinder Image](/images/wayfinder.jpg)
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Use of Glucocorticoids in Pregnancy
Current Pharmaceutical Design Design and Synthesis of Carbohydrate Derivatives for Antagonistic Activity at Muscarinic Receptor
Letters in Drug Design & Discovery Growing up in the Web of Social Networking: Adolescent Development and Social Media
Adolescent Psychiatry Machine Learning in Discovery of New Antivirals and Optimization of Viral Infections Therapy
Current Medicinal Chemistry Modifying Anti-Inflammatory Effect of Diclofenac with Murraya koenigii
Recent Patents on Inflammation & Allergy Drug Discovery Impact of Phytomolecules with Nanotechnology on the Treatment of Inflammation
Current Bioactive Compounds Matrine: Bioactivities and Structural Modifications
Current Topics in Medicinal Chemistry Chemokines as Pharmacological Targets
Mini-Reviews in Medicinal Chemistry Editorial [ Hot Topic: State of the Science: Pediatric Asthma (Guest Editors: Barbara Velsor-Friedrich and Arlene Butz)]
Current Pediatric Reviews ADAMs and Ectododomain Proteolytic Shedding in Leucocyte Migration: Focus on L-Selectin and ADAM17
Current Immunology Reviews (Discontinued) The Cellular Effects of Carbon Monoxide in the Airway
Current Molecular Medicine Vaccines For Type 1 Diabetes: Prevention or Reversal?
Current Diabetes Reviews Electronic Nose and Exhaled Breath NMR-based Metabolomics Applications in Airways Disease
Current Topics in Medicinal Chemistry A Review on Plant Antimicrobials of Past Decade
Current Topics in Medicinal Chemistry Phenolic Content in Traditionally Processed Erythrina indica L. Seeds: Antioxidant Potential and Type II Diabetes Related Functionality
Current Nutrition & Food Science Remdesivir and Hydroxychloroquine: A Compassionate Use in Covid-19
Current Drug Targets S100A8/A9 as a Pro-inflammatory Cytokine in Obstructive Airway Disease Via the Multi-Ligand Receptor, RAGE
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Targeting JAK3 Tyrosine Kinase-Linked Signal Transduction Pathways with Rationally-Designed Inhibitors
Anti-Cancer Agents in Medicinal Chemistry Pulmonary Embolism and Pregnancy
Current Women`s Health Reviews Start Small and Stay Small: Minimizing Attrition in the Clinic with a Focus on CNS Therapeutics
Current Topics in Medicinal Chemistry